267 related articles for article (PubMed ID: 29778894)
1. New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity.
Durcik M; Lovison D; Skok Ž; Durante Cruz C; Tammela P; Tomašič T; Benedetto Tiz D; Draskovits G; Nyerges Á; Pál C; Ilaš J; Peterlin Mašič L; Kikelj D; Zidar N
Eur J Med Chem; 2018 Jun; 154():117-132. PubMed ID: 29778894
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors.
Durcik M; Tammela P; Barančoková M; Tomašič T; Ilaš J; Kikelj D; Zidar N
ChemMedChem; 2018 Jan; 13(2):186-198. PubMed ID: 29206345
[TBL] [Abstract][Full Text] [Related]
3. An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors.
Tiz DB; Skok Ž; Durcik M; Tomašič T; Mašič LP; Ilaš J; Zega A; Draskovits G; Révész T; Nyerges Á; Pál C; Cruz CD; Tammela P; Žigon D; Kikelj D; Zidar N
Eur J Med Chem; 2019 Apr; 167():269-290. PubMed ID: 30776691
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Evaluation of Novel Tyrosine-Based DNA Gyrase B Inhibitors.
Cotman AE; Trampuž M; Brvar M; Kikelj D; Ilaš J; Peterlin-Mašič L; Montalvão S; Tammela P; Frlan R
Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28621824
[TBL] [Abstract][Full Text] [Related]
5. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV.
Hofny HA; Mohamed MFA; Gomaa HAM; Abdel-Aziz SA; Youssif BGM; El-Koussi NA; Aboraia AS
Bioorg Chem; 2021 Jul; 112():104920. PubMed ID: 33910078
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of 1-ethyl-3-(thiazol-2-yl)urea derivatives as Escherichia coli DNA gyrase inhibitors.
Tomašič T; Barančoková M; Zidar N; Ilaš J; Tammela P; Kikelj D
Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29239018
[TBL] [Abstract][Full Text] [Related]
8. New N-phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATPase inhibitors of DNA gyrase.
Zidar N; Tomašič T; Macut H; Sirc A; Brvar M; Montalvão S; Tammela P; Ilaš J; Kikelj D
Eur J Med Chem; 2016 Jul; 117():197-211. PubMed ID: 27100032
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors.
Liu JJ; Sun J; Fang YB; Yang YA; Jiao RH; Zhu HL
Org Biomol Chem; 2014 Feb; 12(6):998-1008. PubMed ID: 24382549
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel multi-substituted benzo-indole pyrazole schiff base derivatives with antibacterial activity targeting DNA gyrase.
Liu H; Chu ZW; Xia DG; Cao HQ; Lv XH
Bioorg Chem; 2020 Jun; 99():103807. PubMed ID: 32272364
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors.
Gjorgjieva M; Tomašič T; Barančokova M; Katsamakas S; Ilaš J; Tammela P; Peterlin Mašič L; Kikelj D
J Med Chem; 2016 Oct; 59(19):8941-8954. PubMed ID: 27541007
[TBL] [Abstract][Full Text] [Related]
12. Second-generation 4,5,6,7-tetrahydrobenzo[
Lamut A; Skok Ž; Barančoková M; Gutierrez LJ; Cruz CD; Tammela P; Draskovits G; Szili PÉ; Nyerges Á; Pál C; Molek P; Bratkovič T; Ilaš J; Zidar N; Zega A; Enriz RD; Kikelj D; Tomašič T
Future Med Chem; 2020 Feb; 12(4):277-297. PubMed ID: 32043377
[No Abstract] [Full Text] [Related]
13. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents.
Alagumuthu M; Arumugam S
Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site.
Tomašič T; Katsamakas S; Hodnik Ž; Ilaš J; Brvar M; Solmajer T; Montalvão S; Tammela P; Banjanac M; Ergović G; Anderluh M; Peterlin Mašič L; Kikelj D
J Med Chem; 2015 Jul; 58(14):5501-21. PubMed ID: 26098163
[TBL] [Abstract][Full Text] [Related]
15. Design, green one-pot synthesis and molecular docking study of novel N,N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV.
Metwally NH; Abdallah SO; Mohsen MMA
Bioorg Chem; 2020 Apr; 97():103672. PubMed ID: 32145481
[TBL] [Abstract][Full Text] [Related]
16. New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens.
Durcik M; Nyerges Á; Skok Ž; Skledar DG; Trontelj J; Zidar N; Ilaš J; Zega A; Cruz CD; Tammela P; Welin M; Kimbung YR; Focht D; Benek O; Révész T; Draskovits G; Szili PÉ; Daruka L; Pál C; Kikelj D; Mašič LP; Tomašič T
Eur J Med Chem; 2021 Mar; 213():113200. PubMed ID: 33524686
[TBL] [Abstract][Full Text] [Related]
17. Dual Escherichia coli DNA Gyrase A and B Inhibitors with Antibacterial Activity.
Fois B; Skok Ž; Tomašič T; Ilaš J; Zidar N; Zega A; Peterlin Mašič L; Szili P; Draskovits G; Nyerges Á; Pál C; Kikelj D
ChemMedChem; 2020 Feb; 15(3):265-269. PubMed ID: 31721445
[TBL] [Abstract][Full Text] [Related]
18. Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors.
Jakopin Ž; Ilaš J; Barančoková M; Brvar M; Tammela P; Sollner Dolenc M; Tomašič T; Kikelj D
Eur J Med Chem; 2017 Apr; 130():171-184. PubMed ID: 28246042
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of 4,5-dibromo-N-(thiazol-2-yl)-1H-pyrrole-2-carboxamide derivatives as novel DNA gyrase inhibitors.
Tomašič T; Mirt M; Barančoková M; Ilaš J; Zidar N; Tammela P; Kikelj D
Bioorg Med Chem; 2017 Jan; 25(1):338-349. PubMed ID: 27838171
[TBL] [Abstract][Full Text] [Related]
20. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
